1245646-51-8

Basic information

• Product Name: (1R,5S)-tert-butyl 3-(((trifluoromethyl)sulfonyl)oxy)-8-azabicyclo[3.2.1 ]oct-2-ene-8-carboxylate
• CAS NO: 1245646-51-8
• Molecular Weight: 357.351
• Mol File: 1245646-51-8.mol
• Article Data: 33

Chemical Properties

• CAS DataBase Reference: (1R,5S)-tert-butyl 3-(((trifluoromethyl)sulfonyl)oxy)-8-azabicyclo[3.2.1 ]oct-2-ene-8-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: (1R,5S)-tert-butyl 3-(((trifluoromethyl)sulfonyl)oxy)-8-azabicyclo[3.2.1 ]oct-2-ene-8-carboxylate(1245646-51-8)
• EPA Substance Registry System: (1R,5S)-tert-butyl 3-(((trifluoromethyl)sulfonyl)oxy)-8-azabicyclo[3.2.1 ]oct-2-ene-8-carboxylate(1245646-51-8)

Safety Data

• Hazardous Substances Data: 1245646-51-8(Hazardous Substances Data)

Usage

General Description

The chemical "(1R,5S)-tert-butyl 3-(((trifluoromethyl)sulfonyl)oxy)-8-azabicyclo[3.2.1]oct-2-ene-8-carboxylate" is a complex compound with a molecular structure containing a tert-butyl group, a trifluoromethylsulfonyl group, and an azabicyclo[3.2.1]oct-2-ene-8-carboxylate moiety. It is classified as a carboxylate ester and is commonly used in organic synthesis and pharmaceutical research. (1R,5S)-tert-butyl 3-(((trifluoromethyl)sulfonyl)oxy)-8-azabicyclo[3.2.1 ]oct-2-ene-8-carboxylate may have potential applications in the development of new drugs or as a building block for creating more complex chemical structures. Its specific properties and potential uses would need to be further investigated through experimental studies.

Upstream product

• 37595-74-7 N,N-phenylbistrifluoromethane-sulfonimide 
• 185099-67-6 Boc-tropinone 
• 185099-67-6 N-Boc-nortropinone 
• 542-05-2 acetonedicarboxylic acid 
• 24424-99-5 di-tert-butyl dicarbonate 
• 28957-72-4 N-benzylnortropinone 
• 358-23-6 trifluoromethylsulfonic anhydride 
• 5632-84-8 8-azabicyclo[3.2.1]octan-3-one 
• 145100-51-2 N-(5-chloropyridin-2-yl)-1,1,1-trifluoro-N-[(trifluoromethyl)sulphonyl]methanesulphonamide 
• 5632-84-8 nortropinone 
• 25602-68-0 3-oxo-8-azabicyclo[3.2.1]octane hydrochloride 
• 532-24-1 tropinone 

Downstream Products

• 900503-08-4 3-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)-8-azabicyclo[3.2.1]oct-2-ene-8-carboxylic acid tert-butyl ester 
• 1319255-25-8 tert-butyl 3-(7-(bis((2-(trimethylsilyl)ethoxy)methyl)amino)-3-(6-phenylpyridin-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl)-8-azabicyclo[3.2.1]octane-8-carboxylate 
• 1319255-26-9 tert-butyl 3-(7-(bis((2-(trimethylsilyl)ethoxy)methyl)amino)-6-bromo-3-(6-phenylpyridin-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl)-8-azabicyclo[3.2.1]octane-8-carboxylate 
• 1319255-27-0 tert-butyl 3-(7-(bis((2-(trimethylsilyl)ethoxy)methyl)amino)-6-(1-ethoxyvinyl)-3-(6-phenylpyridin-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl)-8-azabicyclo[3.2.1]octane-8-carboxylate 
• 1421271-46-6 5-((1R,3s,5S)-8-azabicyclo[3.2.1]octan-3-yl)-3-(6-phenylpyridin-3-yl)-8-pyrazolo[1,5-a]pyrrolo[3,2-e]pyrimidine 
• 1421271-38-6 C₂₉H₂₅N₉O 
• 949901-52-4 3-endo-(8-aza-bicyclo[3.2.1]oct-3-yl)-phenol 
• 179022-43-6 methyl 8-(1-(2-chloro-6-(trifluoromethyl)benzoyl)-1H-pyrazolo[4,3-b]pyridin-3-yl)-8-aza-bicyclo[3.2.1]octane-3-carboxylate 

Relevant articles and documents

Carbonyl 1,2-transposition through triflate-mediated a-amination

To date, it remains challenging to selectively migrate a carbonyl oxygen within a given molecular scaffold, especially to an adjacent carbon. In this work, we describe a simple one- or two-pot protocol that transposes a ketone to the vicinal carbon. This approach first converts the ketone to the corresponding alkenyl triflate, which can then undergo the palladium- and norbornene-catalyzed regioselective a-amination and ipso-hydrogenation enabled by a bifunctional hydrogen and nitrogen donor. The resulting "transposed enamine" intermediate can subsequently be hydrolyzed to produce the 1,2-carbonyl-migrated product. This method allows rapid access to unusual bioactive analogs through late-stage functionalization.

Compound and application thereof

The invention provides a novel compound. The novel compound has certain inhibitory activity for indoleamine 2,3-dioxygenase (IDO) which is oxido-reductase, and accordingly the novel compound can be used for treating diseases related to the indoleamine 2,3-dioxygenase and can be applied to cancer and immunity related diseases.

OXALAMIDES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE

The present invention relates to novel compounds which act as modulators of indoleamine 2,3-dioxygenase (IDOl) and to the use of said compounds in the prophylaxis and/or treatment of diseases or conditions mediated by indoleamine 2,3-dioxygenase. The inve